New Day Therapeutics Overview
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
New Day Therapeutics General Information
Description
Operator of an app-based patient management platform intended to support the treatment of PTSD and depression with ketamine therapy. The company's platform provides a secure portal for healthcare providers to oversee patient treatment, track symptoms, and manage dosages, enabling healthcare providers to safely and efficiently manage patients receiving this therapy and to intervene in advance of a crisis.
Contact Information
Website
newdaythera.comCorporate Office
- Granville, OH 43023
- United States
Corporate Office
- Granville, OH 43023
- United States
New Day Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 12-Sep-2025 | Completed | Startup |
New Day Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Caduceus Capital Partners | Venture Capital | Minority |
New Day Therapeutics FAQs
-
Where is New Day Therapeutics headquartered?
New Day Therapeutics is headquartered in Granville, OH.
-
What industry is New Day Therapeutics in?
New Day Therapeutics’s primary industry is Other Healthcare Technology Systems.
-
Is New Day Therapeutics a private or public company?
New Day Therapeutics is a Private company.
-
What is New Day Therapeutics’s current revenue?
The current revenue for New Day Therapeutics is .
-
Who are New Day Therapeutics’s investors?
Caduceus Capital Partners has invested in New Day Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process